{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:48:41Z","timestamp":1782762521149,"version":"3.54.5"},"reference-count":31,"publisher":"Informa UK Limited","issue":"30","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Novartis Pharmaceuticals"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.1080\/14796694.2025.2595691","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:26:55Z","timestamp":1764322015000},"page":"3957-3968","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Long-term safety and effectiveness of ruxolitinib in Japanese patients with polycythemia vera: a post-marketing study"],"prefix":"10.1080","volume":"21","author":[{"given":"Tomoko","family":"Hayashi","sequence":"first","affiliation":[{"name":"Novartis Pharma K.K","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Hongo","sequence":"additional","affiliation":[{"name":"Novartis Pharma K.K","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhe","family":"Lu","sequence":"additional","affiliation":[{"name":"Novartis Pharma K.K","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.20377"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106629"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27002"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-208520"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22365"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03412-x"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.062"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00581-6"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017697"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.36748\/ijswc.3.4_132"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02887-w"},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02964-0"},{"key":"e_1_3_9_15_1","unstructured":"Jakavi prescribing information for ruxolitinib. Japan: Pharmaceuticals and Medical Devices Agency; 2025 [cited 2025 Apr 7]. Available from: https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/300242_4291034F1029_1_13;"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2333-y"},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30207-8"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00102-8"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409002"},{"key":"e_1_3_9_20_1","unstructured":"Ministry of Health LaWM. Ordinance no. 171 of 2004 ministerial ordinance on good post-marketing study practice for drugs (GPSP). 2004."},{"key":"e_1_3_9_21_1","first-page":"75","article-title":"Jakafi (Ruxolitinib): first FDA-approved medication for the treatment of patients with polycythemia vera","volume":"8","author":"Raedler LA","year":"2015","unstructured":"Raedler LA. Jakafi (Ruxolitinib): first FDA-approved medication for the treatment of patients with polycythemia vera. Am Health Drug Benefits. 2015;8(Spec Feature):75.","journal-title":"Am Health Drug Benefits"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01935"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27400"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30558-7"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.06009"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3365-y"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14124"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.804.804"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1337507"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12787"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13136"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208500"},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182706"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2595691","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2025.2595691","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2595691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:18:39Z","timestamp":1782760719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2595691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":31,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025,12,20]]}},"alternative-id":["10.1080\/14796694.2025.2595691"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2595691","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}